jf-executivenews.blogspot.com
JF Executive News: October 2010
http://jf-executivenews.blogspot.com/2010_10_01_archive.html
Monday, 18 October 2010. Manufacturing Safety Raises Concern. Last week Pharmaceutical heads met as a result of a drugs recall after a pill mix up of breast cancer pills. The drug, Fresenius Kabi’s Anastrozole, was made by the German company’s subsidiary in India. The ingredient mix up led to the voluntary recall of 7,192 bottles, each containing 30 tablets. The mishap raises the question: Is there enough regulation to protect patients? Giles Snare - Head of Life Sciences, Bioquell and Richard Lucas - Bi...